| Nov. 19, 2019 |
H.RES.715 |
Recognizing Survivors Victory Day to celebrate and honor the victims and survivors of trauma. |
0 |
|
Referred to the House Committee on Oversight and Reform. |
| April 17, 2013 |
H.R.1591 |
To amend the Public Health Service Act to provide for the establishment and maintenance of an undiagnosed diseases network, and for other purposes. |
13 |
Bipartisan |
Referred to the Subcommittee on Health. |
| July 24, 2012 |
H.R.6174 |
To amend section 403 of the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants, similar retail food establishments, and vending machines. |
47 |
Bipartisan |
Referred to the Subcommittee on Health. |
| July 27, 2011 |
H.R.2671 |
To amend the Public Health Service Act to provide for the establishment and maintenance of an undiagnosed diseases network, and for other purposes. |
9 |
Bipartisan |
Referred to the Subcommittee on Health. |
| Jan. 12, 2011 |
H.J.RES.19 |
Disapproving a rule submitted by the Department of Health and Human Services relating to "Health Insurance Issuers Implementing Medical Loss Ratio (MLR) Requirements Under the Patient Protection and Affordable Care Act". |
1 |
All Republicans |
Referred to the Subcommittee on Health. |
| Dec. 9, 2010 |
H.J.RES.103 |
Disapproving a rule submitted by the Department of Health and Human Services relating to "Health Insurance Issuers Implementing Medical Loss Ratio (MLR) Requirements Under the Patient Protection and Affordable Care Act". |
1 |
All Republicans |
Referred to the House Committee on Energy and Commerce. |
| May 21, 2009 |
H.R.2538 |
To amend the Public Health Service Act to provide for the establishment and maintenance of an undiagnosed diseases registry. |
6 |
Bipartisan |
Referred to the Subcommittee on Health. |
| Oct. 8, 2004 |
H.R.5306 |
To amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for cancer drugs, and to amend title 35, United States Code, to provide for the extension of the patent term on such drugs equal to the regulatory review period for such drugs. |
0 |
All Republicans |
Referred to the Subcommittee on Courts, the Internet, and Intellectual Property. |
Searching...